Prior human papillomavirus‐16/18 AS04‐adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post‐hoc analysis from a randomized controlled trial

We evaluated the efficacy of the human papillomavirus (HPV)−16/18 AS04‐adjuvanted vaccine in preventing HPV‐related disease after surgery for cervical lesions in a post‐hoc analysis of the PApilloma TRIal against Cancer In young Adults (PATRICIA; NCT00122681). Healthy women aged 15–25 years were ran...

Descripción completa

Detalles Bibliográficos
Autores principales: Garland, Suzanne M., Paavonen, Jorma, Jaisamrarn, Unnop, Naud, Paulo, Salmerón, Jorge, Chow, Song‐Nan, Apter, Dan, Castellsagué, Xavier, Teixeira, Júlio C., Skinner, S. Rachel, Hedrick, James, Limson, Genara, Schwarz, Tino F., Poppe, Willy A.J., Bosch, F. Xavier, de Carvalho, Newton S., Germar, Maria Julieta V., Peters, Klaus, Del Rosario‐Raymundo, M. Rowena, Catteau, Grégory, Descamps, Dominique, Struyf, Frank, Lehtinen, Matti, Dubin, Gary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Cancer Therapy and Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412942/
https://www.ncbi.nlm.nih.gov/pubmed/27541373
http://dx.doi.org/10.1002/ijc.30391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412942/
https://www.ncbi.nlm.nih.gov/pubmed/27541373
http://dx.doi.org/10.1002/ijc.30391

Ejemplares similares